16-84170127-C-T

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2

The NM_178452.6(DNAAF1):​c.1299C>T​(p.Asp433Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000308 in 1,569,810 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00045 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00029 ( 3 hom. )

Consequence

DNAAF1
NM_178452.6 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: -2.66

Publications

1 publications found
Variant links:
Genes affected
DNAAF1 (HGNC:30539): (dynein axonemal assembly factor 1) The protein encoded by this gene is cilium-specific and is required for the stability of the ciliary architecture. It is involved in the regulation of microtubule-based cilia and actin-based brush border microvilli. Mutations in this gene are associated with primary ciliary dyskinesia-13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNAAF1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 13
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 16-84170127-C-T is Benign according to our data. Variant chr16-84170127-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 262939.
BP7
Synonymous conserved (PhyloP=-2.66 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 3 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAAF1NM_178452.6 linkc.1299C>T p.Asp433Asp synonymous_variant Exon 8 of 12 ENST00000378553.10 NP_848547.4 Q8NEP3-1A0A140VJN4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAAF1ENST00000378553.10 linkc.1299C>T p.Asp433Asp synonymous_variant Exon 8 of 12 1 NM_178452.6 ENSP00000367815.5 Q8NEP3-1

Frequencies

GnomAD3 genomes
AF:
0.000450
AC:
63
AN:
140010
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000408
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000500
Gnomad ASJ
AF:
0.00681
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000686
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000170
Gnomad OTH
AF:
0.00207
GnomAD2 exomes
AF:
0.000490
AC:
123
AN:
251192
AF XY:
0.000457
show subpopulations
Gnomad AFR exome
AF:
0.000554
Gnomad AMR exome
AF:
0.000377
Gnomad ASJ exome
AF:
0.00695
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000185
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000294
AC:
420
AN:
1429690
Hom.:
3
Cov.:
96
AF XY:
0.000288
AC XY:
205
AN XY:
710662
show subpopulations
African (AFR)
AF:
0.000397
AC:
13
AN:
32750
American (AMR)
AF:
0.000392
AC:
17
AN:
43386
Ashkenazi Jewish (ASJ)
AF:
0.00845
AC:
210
AN:
24848
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36754
South Asian (SAS)
AF:
0.000204
AC:
17
AN:
83196
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52814
Middle Eastern (MID)
AF:
0.000183
AC:
1
AN:
5464
European-Non Finnish (NFE)
AF:
0.000115
AC:
126
AN:
1091988
Other (OTH)
AF:
0.000615
AC:
36
AN:
58490
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
31
62
94
125
156
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000450
AC:
63
AN:
140120
Hom.:
0
Cov.:
32
AF XY:
0.000469
AC XY:
32
AN XY:
68182
show subpopulations
African (AFR)
AF:
0.000407
AC:
15
AN:
36880
American (AMR)
AF:
0.000499
AC:
7
AN:
14024
Ashkenazi Jewish (ASJ)
AF:
0.00681
AC:
23
AN:
3378
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4710
South Asian (SAS)
AF:
0.000687
AC:
3
AN:
4366
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8964
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
0.000170
AC:
11
AN:
64798
Other (OTH)
AF:
0.00205
AC:
4
AN:
1950
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000848
Hom.:
0
EpiCase
AF:
0.000436
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:2
Apr 04, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Nov 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia 13 Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.25
DANN
Benign
0.14
PhyloP100
-2.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141074491; hg19: chr16-84203733; COSMIC: COSV100533617; API